National Economic Council Director Kevin Hassett discusses America’s economic trajectory, including the jobs market and productivity, inflation, and President Trump’s pick for new Fed chair, Kevin Warsh. Direct-to-consumer telehealth Hims & Hers made waves last month when it announced a cheaper, compounded obesity pill similar to Wegovy. Now, after the FDA warned against compounded GLP-1s, Hims & Hers is backing off. Former FDA Commissioner Dr. Scott Gottlieb discusses competition in obesity drugs, Novo Nordisk’s lawsuit against Hims & Hers, and the importance of vaccines. Plus, the pharma and AI ads at Super Bowl LX, Japanese Prime Minister Sanae Takaichi secured a supermajority in a snap election, and CNBC’s Emily Wilkins reports on the legislative efforts to address the U.S. housing affordability crisis. Emily Wilkins - Kevin Hassett - Dr. Scott Gottlieb - In this episode:Emily Wilkins, @emrwilkinsBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY